10x Genomics, Inc.
TXG
$10.61
-$1.09-9.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.16% | 61.55% | 39.28% | -18.13% | -184.36% |
| Total Depreciation and Amortization | -9.76% | -5.87% | -8.23% | 33.40% | 38.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.96% | -16.06% | -21.22% | -11.23% | 9.87% |
| Change in Net Operating Assets | -108.06% | -19.65% | 59.08% | -5.65% | 188.22% |
| Cash from Operations | -126.20% | 185.52% | 165.04% | -281.21% | 87.70% |
| Capital Expenditure | 21.28% | 74.47% | 88.65% | 36.17% | 91.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -395.36% | -98.65% | -29.05% | -89.12% | 82.61% |
| Cash from Investing | -493.89% | -173.84% | 367.75% | -91.14% | 139.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -19.53% | -96.43% | -35.13% | -31.75% | 12.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -19.53% | -96.43% | -35.13% | 147.98% | 12.24% |
| Foreign Exchange rate Adjustments | -449.35% | 283.53% | 93.88% | -300.00% | -69.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -221.43% | 213.78% | 368.91% | -103.12% | 413.77% |
